Effectivity of Slackline-Training in Physiotherapy

NCT02218086 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-10-08

No results posted yet for this study

Summary

Slacklines have been established in the last few years as a training equipment in sports such as climbing, skiing and others to increase postural control. Furthermore, slacklines are used in physiotherapy in terms of stabilizing training such as wobbling boards.

However, if slackline training is effective in rehabilitation has not been investigated yet. Therefore, to goal of this study will be to investigate the effectivity of slackline training in physiotherapy compared to a wobbling board with a single tilting axis.

Outcomes will be electromyographic-data and the kinetics of the whole body.

Conditions

  • Healthy Volunteers
  • Persons With no Known Significant Health Problems

Interventions

DEVICE

Slackline

Slackbase PRO CE: certificated by european law for medical devices (EG Richtlinie 93/42/EWG)

DEVICE

Wobbling Board

Wobbling Board CE: certificated by european law for medical devices (EG Richtlinie 93/42/EWG)

DEVICE

Pre-training

First investigation of the beginners with less than 1 hour experience with slacklining.

DEVICE

Fix visual anchor

Professionals have to gaze at a fixed visual anchor during the slacklining.

DEVICE

Moving visual anchor

Professionals have to gaze at a moving visual anchor during the slacklining.

DEVICE

Post-training

Second investigation of the beginners occurs after a training session of 9 times 30 minutes within a few weeks.

DEVICE

Slackline vs. standing-on-1-leg vs. control

beginners have to train 9 times \~15minutes within y few weeks.

Sponsors & Collaborators

  • Vrije Universiteit Brussel

    collaborator OTHER
  • THIM - die internationale Hochschule für Physiotherapie

    lead OTHER

Principal Investigators

  • Ursula M Kueng, PhD · THIM - die internationale Hochschule für Physiotherapie

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-08-01
Primary Completion
2020-05-31
Completion
2020-05-31

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02218086 on ClinicalTrials.gov